FMP

FMP

Enter

AXDX - Accelerate Diag...

photo-url-https://images.financialmodelingprep.com/symbol/AXDX.png

Accelerate Diagnostics, Inc.

AXDX

NASDAQ

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

1.11 USD

0.035 (3.15%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Jack Phillips

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk....

CIK

0000727207

ISIN

US00430H2013

CUSIP

00430H102

Address

3950 South Country Club Road

Phone

520 365 3100

Country

US

Employee

134

IPO Date

Apr 7, 1994

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

AXDX Financial Summary

CIK

0000727207

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

00430H102

ISIN

US00430H2013

Country

US

Price

1.11

Beta

0.6

Volume Avg.

64.61k

Market Cap

27.8M

Shares

-

52-Week

0.73-4.28

DCF

1.73

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.43

P/B

-

Website

https://acceleratediagnostics.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest AXDX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep